Press release
Breaking Down Cushings Syndrome and Acromegaly Treatment Market Trends
Cushings Syndrome and Acromegaly Treatment Market 2023The physicians' as well as patients' experiences are being enhanced by VR (Virtual reality) and AR (Augmented Reality). The major application areas include training surgeons and physicians with various essential insights. Various players are also teaming up for making important decisions, so as to assure of consent of patients. The Cushings Syndrome and Acromegaly Treatment Market would go along these lines going forward.
Persistence Market Research (PMR) delivers the key insights on the global Cushing's Syndrome and Acromegaly treatment market in its upcoming report titled "Cushing's Syndrome and Acromegaly Treatment Market: Global Industry Analysis 2013-2017 and Forecast 2018 - 2026". In terms of revenue, the global Cushing's syndrome and Acromegaly treatment market is projected to register a CAGR of 9.3% over the forecast period.
๐๐ฒ๐ ๐๐ฟ๐ฒ๐ฒ ๐ฆ๐ฎ๐บ๐ฝ๐น๐ฒ ๐๐ผ๐ฝ๐ ๐ข๐ณ ๐๐๐๐ต๐ถ๐ป๐ด๐ ๐ฆ๐๐ป๐ฑ๐ฟ๐ผ๐บ๐ฒ ๐๐ป๐ฑ ๐๐ฐ๐ฟ๐ผ๐บ๐ฒ๐ด๐ฎ๐น๐ ๐ง๐ฟ๐ฒ๐ฎ๐๐บ๐ฒ๐ป๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐@ https://www.persistencemarketresearch.com/samples/24664
The Cushing's syndrome and Acromegaly treatment is segmented based on drug type, distribution channels and regions. Based on the drug type, the Cushing's syndrome and Acromegaly Treatment is segmented into Cushing's syndrome treatment and Acromegaly treatment. The Cushing's syndrome treatment is further sub segmented into Glucocorticoid Receptor Inhibitors, Somatostatin, and other Off-label.
Company Profiles
โข Novartis AG
โข Corcept Therapeutics
โข HRA Pharma
โข Bristol-Myers Squibb Company
โข Pfizer Inc.
โข Ipsen Biopharmaceuticals, Inc.
โข Others.
The Acromegaly treatment is further sub segmented into Somatostatin, Glucocorticoid Receptor Inhibitors, and other Off-label. Based on the distribution channels, the global Cushing's syndrome and Acromegaly treatment market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
The Cushing's syndrome treatment segment is expected to be the leading segment in the Cushing's Syndrome and Acromegaly Treatment market over the forecast period. The Cushing's syndrome treatment segment is expected to witness a high growth at a CAGR of 9.5% over the forecast period.
๐ฆ๐๐ถ๐๐ฐ๐ต ๐ข๐๐ฒ๐ฟ ๐ง๐ผ ๐ง๐ต๐ฒ "๐ ๐ฒ๐๐ต๐ผ๐ฑ๐ผ๐น๐ผ๐ด๐" ๐ง๐ฎ๐ฏ@ https://www.persistencemarketresearch.com/methodology/24664
The Cushing's syndrome and Acromegaly Treatment market is also segmented based on the distribution channels. The hospital pharmacies segment in the Cushing's syndrome and Acromegaly treatment market is expected to have a dominant share, while the retail pharmacies segment in the Cushing's syndrome and Acromegaly treatment is expected to grow at a CAGR of 9.7 % over the forecast period.
The growth of the global Cushing's syndrome and Acromegaly treatment market is primarily driven by its growing prevalence coupled with the growing awareness and the rate of screening. The development of healthcare infrastructure around the world coupled with the governmental support towards orphan and rare diseases is also expected to drive the growth of the Cushing's syndrome and Acromegaly treatment market.
However, the high cost of drugs coupled with the lower screening rates in the developing world are factors expected to hamper the growth of the market. Government support in terms of orphan drug status and the financial and tax incentives have led to a high return on investment for the Cushing's syndrome and acromegaly treatment market.
In the U.S., incentives include a 7-year period of market exclusivity following product launch, regardless of patent life, a waiver on Food and Drug Administration fees, and 50% tax credit on clinical studies. In the EU, Regulation offers 10-year market exclusivity, with tax credits offered by individual EU markets.
In 2012, FDA Safety Innovation Act that has made rare disease drugs to progress through clinical trials activities. This has translated into driving the global sales of orphan drugs by 10% in a year between 2005-2011, and a 400 orphan drugs approvals in the U.S. and EU region.
This report assesses the trends that are driving the growth of each segment of the Cushing's syndrome and Acromegaly treatment market on the global as well as regional level, and offers potential takeaways that proves substantially useful for manufacturers planning to enter the Cushing's syndrome and Acromegaly treatment market.
๐๐ผ ๐ง๐ผ "๐ฃ๐๐ฟ๐ฐ๐ต๐ฎ๐๐ฒ ๐ก๐ผ๐" ๐ง๐ผ ๐๐ฒ๐ฐ๐ถ๐ฝ๐ต๐ฒ๐ฟ ๐ง๐ต๐ฒ ๐๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐๐ฒ ๐๐ป๐ฎ๐น๐๐๐ถ๐ ๐๐ป ๐ข๐๐ฟ ๐๐๐๐ต๐ถ๐ป๐ด๐ ๐ฆ๐๐ป๐ฑ๐ฟ๐ผ๐บ๐ฒ ๐๐ป๐ฑ ๐๐ฐ๐ฟ๐ผ๐บ๐ฒ๐ด๐ฎ๐น๐ ๐ง๐ฟ๐ฒ๐ฎ๐๐บ๐ฒ๐ป๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐@ https://www.persistencemarketresearch.com/checkout/24664
North America is expected to be the dominant regional market for Cushing's syndrome and Acromegaly treatment, accounting for a high revenue share in 2017.
The U.S. Cushing's Syndrome and Acromegaly Treatment market is expected to account for a large share and to grow at a CAGR of 9.8 % over the forecast period, while Canada is expected to register a CAGR of 9.0%.
Europe and Asia Pacific Cushing's Syndrome and Acromegaly treatment markets collectively are expected to grow at CAGRs of 8.9 % and 10.5%, respectively. The market is expected to shift in favour of developing regions led by Asia Pacific nation of China owing to its fast developing economy and healthcare.
Contact Us:
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About Us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breaking Down Cushings Syndrome and Acromegaly Treatment Market Trends here
News-ID: 3107812 • Views: โฆ
More Releases from Persistence Market Research
Golf Apparel Market valued at $8.5Bn in 2025, growth driven by athleisure & tour โฆ
The global golf apparel market continues to gain momentum as the sport grows in popularity across both professional and recreational segments. According to recent market assessments, the global golf apparel market size is expected to be valued at US$8.5 billion in 2025. It is projected to reach approximately US$12.3 billion by 2032, reflecting a steady compound annual growth rate (CAGR) of around 5.5% during the forecast period from 2025 toโฆ
Inkjet Printers Market Value Rises to US$63.09 Bn by 2032 Driven by Digital Prin โฆ
The global inkjet printers market continues to expand at a robust pace driven by rising digitization, industrial manufacturing advancements, and increasing adoption of high-quality printing technologies across commercial, office, and household environments. According to recent market evaluations, the global inkjet printers market size is likely to be valued at US$42.49 billion in 2025. By 2032, the market is expected to reach US$63.09 billion, progressing at a CAGR of 5.5% duringโฆ
Socks Market Value to Hit $89.9Bn by 2032 Driven by Performance and Specialty De โฆ
The global socks market continues to evolve as manufacturers emphasize comfort, health-focused features, fashion aesthetics, and sustainability. According to recent industry estimates, the worldwide socks market size is likely to be valued at around US$55.65 billion in 2025. The market is set to exhibit consistent expansion and is projected to reach approximately US$89.9 billion by the end of 2032. This growth reflects a steady CAGR of 7.1% during the forecastโฆ
Wine Market Poised for $926.5Bn Value by 2032, Boosted by Premiumization & Lifes โฆ
The global wine market continues its robust growth trajectory, supported by rising premiumization trends, evolving consumer tastes, and increased appreciation for high-quality alcoholic beverages. According to Persistence Market Research, the global wine market is expected to be valued at US$530.2 billion by 2025. It is further projected to reach US$926.5 billion by 2032, expanding at a CAGR of 8.3% during the forecast period of 2025 to 2032. This remarkable growthโฆ
More Releases for Cushing
Myasthenia Gravis Pipeline Outlook Report 2025: Novel Therapeutics, Clinical Adv โฆ
DelveInsight's "Cushing Syndrome Pipeline Insight 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in the Cushing Syndrome pipeline landscape. It covers the Cushing Syndrome Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cushing Syndrome Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious about the latest updatesโฆ
Cushing Syndrome Market Trends is Electrifying Growth Cycle: Bristol Myers Squib โฆ
The latest study released on the Global Cushing Syndrome Market by HTF MI Research evaluates market size, trend, and forecast to 2031. The Cushing Syndrome market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Playersโฆ
Cushing Syndrome Pipeline Appears Robust With 4+ Key Pharma Companies Actively W โฆ
DelveInsight's, "Cushing Syndrome Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Cushing Syndrome pipeline landscape. It covers the Cushing Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cushing Syndrome therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Cushing Syndromeโฆ
Cushing Syndrome Market Is Booming So Rapidly | Recordati, Diurnal Group, Pfizer
The Global Cushing Syndrome Market Size is estimated at $1.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 22.6% to reach $8.8 Billion by 2034.
The latest study released on the Global Cushing Syndrome Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Cushing Syndrome market study covers significant research data and proofs to be a handy resource document forโฆ
The Cushingโs Disease Treatment Market to grow at an invigorating pace in the โฆ
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the diseaseโฆ
Somatostatin Analogs Market Report 2018: Segmentation by Product (Octreotide, La โฆ
Global Somatostatin Analogs market research report provides company profile for Chiasma, Ipsen Biopharmaceutical, Novartis, Peptron and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on the basis ofโฆ
